Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 396, 15-17 (5 November 1998) | doi:10.1038/23810
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Leadership Fellowships
- University of Oxford
- Oxford United Kingdom
Postdoctoral Fellow - Computational Genomics - Team 78 – Ref: 80464
- Wellcome Trust Sanger Institute
- Hinxton, Cambridgeshire CB10 1, UK
Inflammation: A new target for aspirin
Edward A. O'Neill1
"Take two aspirin and call me in the morning" seems like a tired cliché. Nevertheless, for many common physical ailments, low doses of aspirin (acetylsalicylic acid) will make you feel better, and high doses of the drug give sustained relief from the symptoms of chronic inflammatory diseases such as rheumatoid arthritis1.
- Edward A. O'Neill is in the Department of Immunology and Rheumatology, Merck Research Laboratories, PO Box 2000, Rahway, New Jersey 07065-0900, USA.
e-mail: Email: edward_oneill@merck.com
To read this story in full you will need to login or make a payment (see right).
